La eficacia de los a-GLP-1 en la prdida de peso se debe en parte a su capacidad para alterar el apetito y la ingesta de alimentos
Sestrin2 as a novel biomarker and therapeutic target for various diseases
Psychiatry 70 KroenkeK.WuJ.BairM
Bhatt discloses the following relationshipsadvisory board: Boehringer Ingelheim, Cardax, CellProthera, Cereno Scientific, Elsevier Practice Update Cardiology, Janssen, Level Ex, Medscape Cardiology, MyoKardia, NirvaMed, Novo Nordisk, PhaseBio, PLx Pharma, Regado Biosciences, Stasys
It is noteworthy that this superior effectiveness extended to primates (humans and cynomolgus monkeys) and rodent models of obesity and diabetes, such as db/db (diabetic) mice and Zucker diabetic fatty (ZDF) rat
Analytical and Bioanalytical Chemistry , 408 , 3145-3153